These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8099538)
1. A survey of the most important Janssen neuroleptics. Niemegeers CJ Cesk Psychiatr; 1993 Jan; 89(1):3-10. PubMed ID: 8099538 [No Abstract] [Full Text] [Related]
2. Recent news in the chemistry and pharmacology of neuroleptics with special regard to the work carried out in Czechoslovakia. Protiva M Pharmazie; 1986 Apr; 41(4):225-32. PubMed ID: 2873597 [No Abstract] [Full Text] [Related]
3. Scandinavian standpoint on the Liege classification of neuroleptics. Kristjansen P Acta Psychiatr Belg; 1974 Sep; 74(5):462-9. PubMed ID: 4157189 [No Abstract] [Full Text] [Related]
5. The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists. Froimowitz M; Cody V Drug Des Discov; 1997 Aug; 15(2):63-81. PubMed ID: 9342550 [TBL] [Abstract][Full Text] [Related]
6. The main clinical classifications of neuroleptics. Collard J Acta Psychiatr Belg; 1974 Sep; 74(5):447-61. PubMed ID: 4157188 [No Abstract] [Full Text] [Related]
7. [New findings in the chemistry and pharmacology of neuroleptics]. Protiva M Cesk Psychiatr; 1984 Dec; 80(6):381-97. PubMed ID: 6151423 [No Abstract] [Full Text] [Related]
8. QSAR modeling and transmission electron microscopy stereology of altered mitochondrial ultrastructure of white blood cells in patients diagnosed as schizophrenic and treated with antipsychotic drugs. Inuwa IM; Peet M; Williams MA Biotech Histochem; 2005; 80(3-4):133-7. PubMed ID: 16298898 [TBL] [Abstract][Full Text] [Related]
9. [Toxicologic studies on butyrophenone neuroleptics and related substances]. Marsboom R Int Pharmacopsychiatry; 1978; 13 Suppl 1():3-14. PubMed ID: 35475 [No Abstract] [Full Text] [Related]
10. Overall-response parameter analysis applied to butyrophenones. Mager PP Act Nerv Super (Praha); 1981 Jun; 23(2):130-5. PubMed ID: 6115535 [TBL] [Abstract][Full Text] [Related]
11. [Toxic and adverse neurologic effects of neuroleptics]. Nakayama K; Yakutsu N; Koga M Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):532-7. PubMed ID: 10434716 [No Abstract] [Full Text] [Related]
12. Two new phenylpiperazines with atypical antipsychotic potential. Tomić M; Ignjatović D; Tovilović G; Andrić D; Roglić G; Kostić-Rajacić S Bioorg Med Chem Lett; 2007 Nov; 17(21):5749-53. PubMed ID: 17870534 [TBL] [Abstract][Full Text] [Related]
13. [Neuroprotective effect of antipsychotic drugs (neuroleptics) in global brain ischemia]. Kulinskiĭ VI; Gavrilov SS Eksp Klin Farmakol; 2006; 69(4):19-22. PubMed ID: 16995432 [TBL] [Abstract][Full Text] [Related]
15. Visual compatibility of neuroleptics with anticholinergics or antihistamines in polyethylene syringes. Gibler B; Kim MS; Raleigh F Am J Hosp Pharm; 1994 Nov; 51(21):2709-10. PubMed ID: 7856588 [No Abstract] [Full Text] [Related]
16. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently]. MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271 [No Abstract] [Full Text] [Related]
17. Synthesis and evaluation of 1-(quinoliloxypropyl)-4-aryl piperazines for atypical antipsychotic effect. Bali A; Malhotra S; Dhir H; Kumar A; Sharma A Bioorg Med Chem Lett; 2009 Jun; 19(11):3041-4. PubMed ID: 19398330 [TBL] [Abstract][Full Text] [Related]
18. [Antipsychotic agents: from phenothiazines to atypical neuroleptics of the second generation]. Raevskiĭ KS Eksp Klin Farmakol; 2003; 66(2):6-9. PubMed ID: 12962040 [TBL] [Abstract][Full Text] [Related]
19. Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality. Möller HJ Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1101-11. PubMed ID: 14642970 [TBL] [Abstract][Full Text] [Related]
20. [Sedation without risk of addiction--the melperon alternative]. Bengesser G Wien Med Wochenschr; 1995; 145(21):595-7. PubMed ID: 8560904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]